RXO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
RXO Inc. does not present a strong buy opportunity for a beginner, long-term investor at this time. The stock is currently trading flat with no significant upward momentum, and the financial performance and analyst sentiment suggest caution. While insider buying is a positive signal, the lack of strong technical or proprietary trading signals, coupled with weak financials and mixed analyst ratings, makes this stock a hold rather than a buy.
The MACD is positive and expanding, indicating a slight bullish momentum. However, RSI is neutral at 68.516, and moving averages are converging, showing no clear trend. The stock is trading near its pivot point of 14.221, with resistance at 15.202 and support at 13.239, suggesting limited upside potential in the short term.
Insiders are buying, with a 371.98% increase in buying activity over the last month. Analysts at Barclays and Truist have raised price targets recently, citing potential market recovery and improving operating leverage.
The company's Q4 2025 financials show an 11.88% YoY revenue drop and negative net income of -$46M. Analysts from BofA and JPMorgan have lowered price targets, citing weak Q4 results and challenging market conditions. The stock has no recent AI Stock Picker or SwingMax signals, and the pre-market price is down by -2.25%.
In Q4 2025, revenue dropped by 11.88% YoY to $1.469B. Net income improved but remains negative at -$46M, up 84% YoY. EPS increased to -0.27, up 80% YoY. Gross margin dropped to 13%, down 4.55% YoY, indicating ongoing profitability challenges.
Analyst sentiment is mixed. Barclays and Truist are optimistic with higher price targets, while BofA and JPMorgan have lowered targets due to weak financial performance and market challenges. The consensus leans toward caution, with several analysts maintaining Neutral or Hold ratings.
